Physician profile
Joel Thomas
NPI 1710617600
$1,509.26
in general payments reported to CMS, 2019-2025
11 companies · $369 in 2025
The $369 reported for 2025 was more than what 76% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $342 · 2024: $798 · 2025: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,509.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,509.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $465.39 | 2024-2025 | Indigo System |
| Boston Scientific Corporation | $246.57 | 2023-2025 | Spyglass Discover, Obsidio, Wallflex Biliary Transhepatic |
| Trisalus Life Sciences, INC. | $219.29 | 2024 | Trinav Infusion System |
| Medtronic, INC. | $204.81 | 2023 | Osteocool Rf Ablation System, Kyphon Express II Kyphopak Tray |
| Inari Medical, INC. | $178.20 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abiomed | $59.65 | 2025 | |
| Baylis Medical Technologies INC. | $36.33 | 2024 | |
| Guerbet LLC | $31.69 | 2025 | Lipiodol |
| W. L. Gore & Associates, INC. | $23.56 | 2024 | Viatorr Endoprosthesis |
| Surmodics, INC. | $22.33 | 2025 | Sublime Microcatheter, 018, 200cm, Straight, Pounce Venous Thrombectomy System, Pounce Thrombectomy System |
| Sirtex Medical INC | $21.44 | 2024 | Sir-Spheres Microspheres |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.